We are proud to have partnered with ITM Isotope Technologies Munich SE on the appointment of Dr. Andrew Cavey to Chief Executive Officer. #ExecutiveSearch #FindYourLeaders https://lnkd.in/egtF56Xx
Klein Hersh ’s Post
More Relevant Posts
-
Looking for some inspiration on this Monday? We’ve got some for you in this upcoming Webinar featuring our very own Geoff Johnson, MD, PhD. I have the privilege of interviewing Geoff for our first episode of several highlighting the importance of radiopharmaceuticals and the ongoing need for research, development, and utilization of these agents in clinical practice. #radiopharmaceuticals #prostatecancer #NucleusRadioPharma #Mayo #innovation
WEBINAR: Join us on Thursday, July 18 at 12 pm EST for an insightful discussion featuring Geoff Johnson, MD, PhD! We’ll dive into what Novartis’s pursuit of a label expansion for Pluvicto means for patients and the field of radiopharmaceutical therapy. 🔗 Secure your spot and learn more: https://hubs.ly/Q02FfXhY0
Nucleus RadioPharma July Webinar
info.nucleusrad.com
To view or add a comment, sign in
-
Cereno Scientific’s novel HDACi CS014 has potential to become an effective antithrombotic therapy in patients with a high risk of thrombotic events as presented at the ASH Meeting. New preclinical data suggests that CS014 has the potential to enrich the toolbox of anticoagulant therapies in patients with a high risk of thrombotic events without increasing the risk of bleeding. CS014 is a novel histone deacetylase (HDAC) inhibitor that acts as an epigenetic modulator and is in preclinical development as a treatment for thrombosis prevention. The new data was presented at the 65th ASH Annual Meeting & Exposition organized by the American Society of Hematology, in San Diego, US, on December 9-12, 2023. Read more via link.
Read press release >
cerenoscientific.com
To view or add a comment, sign in
-
IT Strategy & Integration | Regulatory Compliance | Innovative Problem-Solving | Cross-Functional Team Leadership | Client Relationship Management | Business Development | Mentor
In case you missed this before the holidays - lots of life sciences M&A activity toward the end of 2023. What will we see in 2024? https://lnkd.in/eXtgce8m #biospace #M&A #lifescienceindustry
Biopharma Closes 2023 with Flurry of M&A Activity from AstraZeneca, BMS, Roche | BioSpace
biospace.com
To view or add a comment, sign in
-
Program Coordinator @ AtomVie Global Radiopharma Inc. | Project Lifecycle Management, Presentation Skills, Communication | Gantt Charts
Many more milestones and anniversaries to come!! #AtomvieGlobalRadiopharma #radiopharmaceuticals #anniversarycelebration #1stanniversary #oneyearanniversary #nuclearmedicine
AtomVie Global Radiopharma Inc.(AtomVie) officially spun out on August 2022. Over the last year, our staff have been working hard to reach significant milestones such as securing a lease agreement for the new facility, closing Series A financing and expanding it to over $90M, establishing new partnerships, and promoting our brand globally. Please check out this celebratory video highlighting a few of our accomplishments during the last year. We look forward to achieving greater milestones in the upcoming years. Follow our LinkedIn for new and exciting updates coming soon. #OneYearAnniversary #Nuclearmedicine #Radiopharmaceuticals #AtomVieGlobalRadiopharma
To view or add a comment, sign in
-
I Have a Better QALY Than You: How to Make Sense of Alternatives to the QALY for Research and Policymaking This promises to be compelling debate at ISPOR with Dan Ollendorf moderating. Our co-founder and chief scientific officer Darius Lakdawalla will be joined by Melanie Whittington and Anirban Basu. Learn more about the panel here: https://lnkd.in/gSAA-HZA #HEOR #ISPOR #DrugPricing #BioPharma #ISPOR24
To view or add a comment, sign in
-
-
Today we recognize World #RNA Day, and the potential future applications of this science. Learn more about our proprietary CASi platform that combines advantageous properties of both single and double-stranded RNAs in a single molecule: https://lnkd.in/gs6fvJEK #RNADay
Our Science with CASi | Switch Therapeutics
https://switchthera.com
To view or add a comment, sign in
-
I am joining ACOP Conference in Oxon Hill (MD) 5-9 Nov https://www.go-acop.org/ where I will be presenting a poster "Benefit of Bayesian borrowing methods in evaluating the impact of newly developed oncology drugs on the standard-of-care (SoC)". do not hesitate to discuss this interesting topic in the context of the FDA Optimus initiative, I will be happy to take your questions. #ACOP #PHARMACOMETRICS #Bayesian approach #Optimus #Drug interaction Optimus
ACoP14
go-acop.org
To view or add a comment, sign in
-
Check out this brilliant paper about a single-cell lipidomics workflow incorporating capillary sampling and LC-MS/MS! #singlecells #lipidomics
Happy to share our workflow for capillary sampled single-cell lipidomics. Thanks to the SEISMIC facility at University of Surrey, Melanie Bailey and Kyle Saunders and all the others for the great teamwork!
Single-Cell Untargeted Lipidomics Using Liquid Chromatography and Data-Dependent Acquisition after Live Cell Selection
pubs.acs.org
To view or add a comment, sign in
-
Ensuring drug stability in space is crucial for future missions due to various factors like radiation, microgravity, and vacuum, which can affect data reliability. Scientists conducted two flight experiments on the International Space Station (ISS) to investigate the stability of an anti-Covid drug formulation, Remdesivir (RDV) sulfobutylether-beta-cyclodextrin (SBECD) complex. For a deeper insight, click on the link and read István Puskás's blog post on Cyclodextrin News: https://lnkd.in/dVF7t39V #cyclolab #cyclodextrin #remdesivir #space #ISS #InternationalSpaceStation #stability #drugstability #covid #covid19 #sarsvoc2 #anticovid #pharma #pharmaceutical #pharmaindustry #science #chemistry #research
Repetitive stability study of Remdesivir/Cyclodextrin complex on ISS
http://cyclodextrinnews.com
To view or add a comment, sign in